Bisphosphonates in the treatment of metabolic bone diseases.

Bisphosphonates in the treatment of metabolic bone diseases.

Item
http://www.wikidata.org/entity/Q40769942
Bone mineral metabolism in pediatric inflammatory bowel disease.Medicinal surface modification of silicon nanowires: impact on calcification and stromal cell proliferationThe effect of dosing regimen on the pharmacokinetics of risedronate.Alendronate for osteoporosis. Safe and efficacious nonhormonal therapyMolecular docking and NMR binding studies to identify novel inhibitors of human phosphomevalonate kinase.Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.Pharmacologic inhibition of particulate-induced bone resorption.The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw.Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells
P2860

Bisphosphonates in the treatment of metabolic bone diseases.

Item
http://www.wikidata.org/entity/Q40769942
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Bisphosphonates in the treatment of metabolic bone diseases.
@en
type
label
Bisphosphonates in the treatment of metabolic bone diseases.
@en
prefLabel
Bisphosphonates in the treatment of metabolic bone diseases.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Bisphosphonates in the treatment of metabolic bone diseases.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698